Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Chefs' Warehouse
CHEF
$4.45B
| $643K | ﹤0.01% |
20,190
-39,711
| -66% | -$1.27M |
|
2902
Akebia Therapeutics
AKBA
$256M
| $642K | ﹤0.01% |
169,276
-67,942
| -29% | -$229K |
|
2903
PUT
Marriott International
MAR
$93.8B
| $642K | ﹤0.01% |
4,700
| – | – |
|
|
RDUS
2904
DELISTED
Radius Health, Inc.
RDUS
| $642K | ﹤0.01% |
35,198
-67,276
| -66% | -$1.34M |
|
2905
PUT
UnitedHealth
UNH
$367B
| $641K | ﹤0.01% |
1,600
| – | – |
|
2906
iShares International Treasury Bond ETF
IGOV
$1.54B
| $640K | ﹤0.01% |
12,252
-138,769
| -92% | -$7.35M |
|
2907
The GEO Group
GEO
$4.03B
| $636K | ﹤0.01% |
89,590
-67,229
| -43% | -$423K |
|
|
NEWR
2908
DELISTED
New Relic, Inc.
NEWR
| $636K | ﹤0.01% |
9,497
+2,754
| +41% | +$177K |
|
2909
RE/MAX Holdings
RMAX
$230M
| $633K | ﹤0.01% |
18,990
-3,990
| -17% | -$143K |
|
2910
Gates Industrial Corporation Ltd.
GTES
$7.24B
| $631K | ﹤0.01% |
34,958
-38,737
| -53% | -$677K |
|
2911
QCR Holdings
QCRH
$1.71B
| $631K | ﹤0.01% |
13,128
-4,325
| -25% | -$207K |
|
2912
Photronics
PLAB
$1.88B
| $630K | ﹤0.01% |
47,674
-44,679
| -48% | -$584K |
|
|
BOCH
2913
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $630K | ﹤0.01% |
41,976
+28,679
| +216% | +$397K |
|
2914
Assembly Biosciences
ASMB
$524M
| $628K | ﹤0.01% |
13,513
+772
| +6% | +$38.2K |
|
2915
Southern First Bancshares
SFST
$604M
| $628K | ﹤0.01% |
12,260
-5,104
| -29% | -$264K |
|
2916
CALL
BlackBerry
BB
$5.15B
| $627K | ﹤0.01% |
51,300
| – | – |
|
2917
Organogenesis Holdings
ORGO
$310M
| $626K | ﹤0.01% |
37,586
+14,941
| +66% | +$279K |
|
|
MAXR
2918
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $625K | ﹤0.01% |
+15,645
| New | +$557K |
|
2919
PUT
Criteo S.A. Ordinary Shares
CRTO
$883M
| $624K | ﹤0.01% |
+13,800
| New | +$532K |
|
|
HFRO
2920
Highland Opportunities and Income Fund
HFRO
$406M
| $624K | ﹤0.01% |
45,349
-82,739
| -65% | -$935K |
|
|
PRO
2921
DELISTED
PROS Holdings
PRO
| $623K | ﹤0.01% |
13,658
-25,805
| -65% | -$1.14M |
|
2922
Ezcorp Inc
EZPW
$1.8B
| $621K | ﹤0.01% |
103,214
-43,368
| -30% | -$274K |
|
2923
Varex Imaging
VREX
$516M
| $618K | ﹤0.01% |
23,061
-34,765
| -60% | -$852K |
|
2924
State Street SPDR S&P Semiconductor ETF
XSD
$2.9B
| $618K | ﹤0.01% |
+3,213
| New | +$577K |
|
|
TRHC
2925
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $617K | ﹤0.01% |
12,328
-14,647
| -54% | -$655K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.